Delivery Order SPE2DB22D1103-SPE2DB24FTHF2
- Not listed
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of VELPHORO 500 MG CHEWABLE TAB 90S, a pharmaceutical product, with a ceiling value of $1,896.89 and a performance period through May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Velphoro 500 mg chewable tablets. The award, with a ceiling value of $4,944.98 and a completion date of April 12, 2024, is not associated with any set-aside designations. Amerisourcebergen Drug Corp serves as a prime contractor for DLA to provide a range of pharmaceutical and medical supplies...
- This federal contract award is a delivery order worth $2,262.32 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of VELPHORO 500 MG CHEWABLE TAB 90S, a pharmaceutical product, with a completion date of February 16, 2024. The contract is a firm fixed price award and does not have a set-aside designation. Amerisourcebergen Drug Corp is an experienced prime contractor...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,880.42 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide VELPHORO 500 MG CHEWABLE TAB 90S, a pharmaceutical product, with a completion date of February 20, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VELPHORO 500 MG CHEWABLE TAB 90S, a pharmaceutical product. The $6,909.21 order has a completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical commodities, including prescription drugs and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,134.47, is a Delivery Order with a Firm Fixed Price pricing type. It covers the procurement of VELPHORO 500 MG CHEWABLE TAB 90S, a pharmaceutical product, with a performance period through December 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Velphoro 500 mg chewable tablets, a medication used in the treatment of hyperphosphatemia in chronic kidney disease patients. The contract has a ceiling value of $1,888.29 and a performance period ending on July 24, 2024. AmerisourceBergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is for the delivery of VELPHORO 500 MG CHEWABLE TAB 90S, a medical product used to treat certain health conditions. The $1,168.09 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $4,489.65 and is for a fixed-price delivery of the pharmaceutical product. The award date is October 15, 2024, and the ultimate completion date is October 16, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Velphoro 500 MG Chewable Tablets in 90-count packages, with a ceiling value of $1,992.86 and an ultimate completion date of May 30, 2025. The contract is not set-aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTHF2Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of VELPHORO 500 MG CHEWABLE TAB 90S, a pharmaceutical product, with a ceiling value of $3,503.22 and a period of performance through March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) that Amerisourcebergen holds with DLA. The IDC has a potential value of up to $999,999,999.00 and is the primary vehicle used by Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 3/27/24 |